MS linked to about 9% of eye nerve inflammation in Japan
By MS Buddy ·
Summarized from Japanese journal of ophthalmology, Nov 2026 · PubMed · DOI. AI-generated summary. Not medical advice.
Observational study · 112 Japanese people with a first episode of eye nerve inflammation
Research by Noriko Himori, Toru Nakazawa and 4 colleagues at Tohoku University Graduate School of Medicine in Japan.
How often is MS found after a first episode of eye nerve inflammation in Japan?
Key Takeaway
MS accounted for about 9% of first episodes of eye nerve inflammation among patients studied at one Japanese hospital.

What They Found
MOG antibody disease (an immune condition that can inflame eye nerves) accounted for about 37% of cases. Neuromyelitis optica (another immune condition that can inflame eye nerves) accounted for about 21%. About 33% had no identified underlying cause, while about 9% had MS. Among patients followed for more than 12 months, about 18% had another attack. Rates of remaining free from another attack did not clearly differ between the disease groups.
Who Should Care and Why
The study included Japanese patients with a first episode of optic neuritis (inflammation of the nerve connecting the eye and brain). Researchers reviewed records from Tohoku University Hospital. MS was one of several underlying diseases studied, rather than the main focus. Patients had blood tests before treatment to look for immune proteins linked to specific diseases. Eye nerve inflammation linked to these immune proteins occurred across a wide age range.
Important Considerations
This study reviewed past medical records from 112 patients at one hospital, rather than randomly assigning treatments. Only 90 patients had follow-up lasting more than 12 months. The abstract does not establish whether early diagnosis or coordinated treatment improved long-term outcomes.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in Japanese journal of ophthalmology by et al.. Reproduced from the PubMed record.
To investigate the distribution of underlying diseases in optic neuritis and related clinical characteristics, treatment strategies, and relapse patterns in Japanese patients using strict radiological diagnostic criteria and pretreatment antibody testing. Retrospective cohort study METHODS: We retrospectively reviewed the charts of 112 patients with first-onset optic neuritis who visited Tohoku University Hospital between March 2016 and November 2025. Diagnoses of optic neuritis were based on visual dysfunction and contrast-enhanced orbital magnetic resonance imaging. Serum anti-myelin oligodendrocyte glycoprotein (MOG) antibodies and anti-aquaporin-4 antibodies were measured using live-cell-based assays before initiation of acute-phase treatment. Patients were classified into groups according to the following underlying diseases: MOG-associated disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis (MS), and idiopathic optic neuritis. Clinical characteristics, treatment strategies, relapse rates, and cumulative relapse rates were analyzed retrospectively. The distribution of underlying diseases was 36.6% MOGAD, 33.0% idiopathic, 21.4% NMOSD, and 8.9% MS. MOGAD patients were characterized by a younger onset, bilateral involvement, and more frequent optic disc swelling, whereas NMOSD patients were predominantly women, older at onset, and had unilateral involvement. Among the 90 patients followed for more than 12 months, the overall relapse rate was 17.8%, with the highest relapse rate observed for NMOSD (25.0%). Kaplan-Meier analysis demonstrated gradually decreasing cumulative relapse-free rates, particularly in NMOSD and idiopathic optic neuritis. The 36-month cumulative relapse-free rates were 81.6% in MOGAD, 87.5% in MS, 72.9% in NMOSD, and 61.3% in idiopathic optic neuritis. No significant difference in relapse-free rates was observed among underlying diseases (log-rank test, p = 0.84). MOGAD and NMOSD accounted for a relatively large proportion of optic neuritis cases in study population. Antibody-associated optic neuritis was observed across a wide age range, suggesting the importance of antibody testing regardless of age. Early diagnosis and multidisciplinary therapeutic intervention may contribute to improved long-term outcomes.
Categories
Explore more research
Related MS research

11/20/2026
In a study of 140 people, a spinal fluid test better separated MS from other nervous system conditio
Read More
11/20/2026
In people with MS, brain scan readings were stronger when images lined up with the scanner’s magneti
Read More
11/20/2026
A study of 59 people with relapsing-remitting MS found a computer tool helped doctors read brain sca
Read More
11/18/2026
An adjusted MRI scan found more veins within MS brain lesions in 17 people with MS. It improved scan
Read More
1/1/2026
After a car crash, brain and spine scans revealed signs of MS in an 18-year-old male. Further tests
Read More
11/14/2026
An opinion paper explains why MS brain scans can show tissue loss without proving nerve signal failu
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
